Becton, Dickinson uses rating-sensitive bridge for Bard takeover
Becton, Dickinson and Co, the US medical devices group, has obtained a $15.7bn bridge loan for its $24bn buyout of CR Bard, a rival in the same industry. The margin will depend on whether BD can hold on to its credit ratings.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts